• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

收缩期双波切迹压力差可识别心动过速性脓毒性休克患者,此类患者在接受药物降心率治疗后有发生心血管失代偿的风险。

Systolic-dicrotic notch pressure difference can identify tachycardic patients with septic shock at risk of cardiovascular decompensation following pharmacological heart rate reduction.

机构信息

Department of Internal Clinical, Anesthesiological and Cardiovascular Sciences, University of Rome, 'La Sapienza', Rome, Italy.

Department of Experimental and Clinical Medicine, Unit of Internal Medicine and Cardiology, University of Florence, Florence, Italy.

出版信息

Br J Anaesth. 2020 Dec;125(6):1018-1024. doi: 10.1016/j.bja.2020.05.058. Epub 2020 Jul 18.

DOI:10.1016/j.bja.2020.05.058
PMID:32690246
Abstract

BACKGROUND

During sepsis, heart rate (HR) reduction could be a therapeutic target, but identification of responders (non-compensatory tachycardia) and non-responders (compensatory for 'fixed' stroke volume [SV]) is challenging. We tested the ability of the difference between systolic and dicrotic pressure (SDP), which reflects the coupling between myocardial contractility and a given afterload, in discriminating the origin of tachycardia.

METHODS

In this post hoc analysis of 45 patients with septic shock with persistent tachycardia, we characterised features of haemodynamic response focusing on SDP, classifying patients according to variations in arterial dP/dt after 4 h of esmolol administration to maintain HR <95 beats min. A cut-off value of 0.9 mm Hg ms was used for group allocation.

RESULTS

After reducing HR, arterial dP/dt remained above the cut-off in 23 patients, whereas it decreased below the cut-off in 22 patients (from 0.99 [0.37] to 0.63 [0.16] mm Hg ms; mean [SD], P<0.001). At baseline, patients with decreased dP/dt after esmolol had lower SDP than those with higher dP/dt (40 [19] vs 53 [16] mm Hg, respectively; P=0.01). The SDP remained unchanged after esmolol in the higher dP/dt group (49 [16] mm Hg), whereas it decreased significantly in patients with lower dP/dt (29 [11] mm Hg; P<0.001). In the latter, the HR reduction resulted in a significant cardiac output reduction with unchanged SV, whereas in patients with higher dP/dt SV increased (from 48 [12] to 67 [14] ml; P<0.001) with maintained cardiac output.

CONCLUSIONS

A decrease in SDP could discriminate between compensatory and non-compensatory tachycardia, revealing a covert loss of myocardial contractility not detected by conventional echocardiographic parameters and deteriorating after HR reduction with esmolol.

CLINICAL TRIAL REGISTRATION

NCT02188888.

摘要

背景

在脓毒症中,心率(HR)降低可能是一个治疗目标,但识别反应者(非代偿性心动过速)和无反应者(“固定”心输出量的代偿性心动过速)具有挑战性。我们测试了收缩压和舒张压之间的差异(SDP)的能力,该差异反映了心肌收缩力与给定后负荷之间的耦合,以区分心动过速的起源。

方法

在这项 45 例脓毒性休克持续心动过速患者的事后分析中,我们以 SDP 为特征,对血流动力学反应的特征进行了分类,根据艾司洛尔给药 4 小时后动脉 dp/dt 的变化,将患者分类,以维持 HR<95 次/分。使用 0.9mm Hg ms 的截断值进行分组分配。

结果

在降低 HR 后,23 例患者的动脉 dp/dt 仍高于截断值,而 22 例患者的动脉 dp/dt 低于截断值(从 0.99 [0.37]降至 0.63 [0.16] mm Hg ms;平均值 [SD],P<0.001)。在基线时,艾司洛尔后 dp/dt 降低的患者的 SDP 低于 dp/dt 较高的患者(分别为 40 [19]与 53 [16] mm Hg;P=0.01)。在 dp/dt 较高的组中,艾司洛尔后 SDP 保持不变(49 [16] mm Hg),而在 dp/dt 较低的患者中,SDP 显著下降(29 [11] mm Hg;P<0.001)。在后者中,HR 降低导致心输出量显著降低,而 SV 不变,而在 dp/dt 较高的患者中,SV 增加(从 48 [12]增加到 67 [14] ml;P<0.001),同时心输出量保持不变。

结论

SDP 的降低可以区分代偿性和非代偿性心动过速,揭示了常规超声心动图参数无法检测到的心肌收缩力的隐性丧失,并在 HR 降低后恶化,用艾司洛尔治疗。

临床试验注册

NCT02188888。

相似文献

1
Systolic-dicrotic notch pressure difference can identify tachycardic patients with septic shock at risk of cardiovascular decompensation following pharmacological heart rate reduction.收缩期双波切迹压力差可识别心动过速性脓毒性休克患者,此类患者在接受药物降心率治疗后有发生心血管失代偿的风险。
Br J Anaesth. 2020 Dec;125(6):1018-1024. doi: 10.1016/j.bja.2020.05.058. Epub 2020 Jul 18.
2
Heart rate reduction with esmolol is associated with improved arterial elastance in patients with septic shock: a prospective observational study.艾司洛尔降低心率与感染性休克患者动脉弹性改善相关:一项前瞻性观察研究。
Intensive Care Med. 2016 Oct;42(10):1528-1534. doi: 10.1007/s00134-016-4351-2. Epub 2016 Apr 21.
3
Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study.早期使用艾司洛尔对高动力型感染性休克的血液动力学和抗炎作用:一项初步研究。
Crit Care. 2021 Jan 7;25(1):21. doi: 10.1186/s13054-020-03445-w.
4
[The value of maximal rate of left ventricular pressure in evaluating cardiac function in patients with sepsis-induced cardiomyopathy].[左心室压力最大上升速率在评估脓毒症性心肌病患者心功能中的价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Jun;35(6):620-626. doi: 10.3760/cma.j.cn121430-20220412-00362.
5
Efficacy and Safety of Esmolol in Treatment of Patients with Septic Shock.艾司洛尔治疗感染性休克患者的疗效与安全性
Chin Med J (Engl). 2016 Jul 20;129(14):1658-65. doi: 10.4103/0366-6999.185856.
6
[The hemodynamic effects of a treatment with beta-receptor blockers during coronary surgery. A comparison between acebutolol and esmolol].[冠状动脉手术期间使用β受体阻滞剂治疗的血流动力学效应。醋丁洛尔与艾司洛尔的比较]
Anaesthesist. 1990 May;39(5):264-8.
7
Continual measurement of arterial dP/dt enables minimally invasive monitoring of left ventricular contractility in patients with acute heart failure.持续测量动脉 dp/dt 可实现对急性心力衰竭患者左心室收缩力的微创监测。
Crit Care. 2019 Nov 21;23(1):364. doi: 10.1186/s13054-019-2654-8.
8
[Effect of esmolol on fluid responsiveness and hemodynamic parameters in patients with septic shock].艾司洛尔对感染性休克患者液体反应性及血流动力学参数的影响
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Nov;27(11):885-9.
9
Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.艾司洛尔对感染性休克患者血流动力学和临床结局的影响:一项随机临床试验。
JAMA. 2013 Oct 23;310(16):1683-91. doi: 10.1001/jama.2013.278477.
10
Microvascular effects of heart rate control with esmolol in patients with septic shock: a pilot study.脓毒性休克患者应用艾司洛尔控制心率的微血管效应:一项初步研究。
Crit Care Med. 2013 Sep;41(9):2162-8. doi: 10.1097/CCM.0b013e31828a678d.

引用本文的文献

1
Can we reliably use pulse pressure as a surrogate for stroke volume? Physiological background and potential clinical implications for shock resuscitation.我们能否可靠地将脉压用作每搏输出量的替代指标?休克复苏的生理背景及潜在临床意义。
Crit Care. 2025 Jun 19;29(1):249. doi: 10.1186/s13054-025-05490-9.
2
Efficacy of Landiolol for Treatment of Sepsis-Related Tachyarrhythmia: Lost in Translation.兰地洛尔治疗脓毒症相关性快速心律失常的疗效:翻译之失。
Am J Cardiovasc Drugs. 2025 Jun 8. doi: 10.1007/s40256-025-00736-x.
3
[Vasoactive agents in septic shock-individualized strategies].
[脓毒性休克中的血管活性药物——个体化策略]
Med Klin Intensivmed Notfmed. 2025 Apr 24. doi: 10.1007/s00063-025-01272-x.
4
Septic Cardiomyopathy: Difficult Definition, Challenging Diagnosis, Unclear Treatment.脓毒症性心肌病:定义困难、诊断棘手、治疗不明
J Clin Med. 2025 Feb 4;14(3):986. doi: 10.3390/jcm14030986.
5
The pros and cons of beta-blockers in sepsis: Where do we stand in 2024?β受体阻滞剂在脓毒症中的利弊:2024年我们处于什么立场?
J Intensive Med. 2024 Aug 7;5(1):32-34. doi: 10.1016/j.jointm.2024.07.002. eCollection 2025 Jan.
6
Comparison of the efficacy and safety of Landiolol and Esmolol in critically ill patients: a propensity score-matched study.兰地洛尔与艾司洛尔在重症患者中的疗效及安全性比较:一项倾向评分匹配研究。
Ann Intensive Care. 2025 Jan 12;15(1):5. doi: 10.1186/s13613-024-01418-8.
7
Landiolol in patients with septic shock.脓毒性休克患者使用兰地洛尔的情况。
Intensive Care Med. 2025 Jan;51(1):221. doi: 10.1007/s00134-024-07706-y. Epub 2024 Nov 11.
8
Heart rate control in septic shock-"every journey begins with a first step" (Confucius).感染性休克中的心率控制——“千里之行,始于足下”(孔子)
Intensive Care Med. 2025 Jan;51(1):222-223. doi: 10.1007/s00134-024-07721-z. Epub 2024 Nov 11.
9
Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP).兰地洛尔用于感染性休克和持续性心动过速患者的心率控制。一项多中心随机临床试验(Landi-SEP)。
Intensive Care Med. 2024 Oct;50(10):1622-1634. doi: 10.1007/s00134-024-07587-1. Epub 2024 Sep 19.
10
Effect of age and gender on ventricular-arterial coupling estimated using a non-invasive technique.年龄和性别对非侵入性技术估计的心室-动脉偶联的影响。
BMC Anesthesiol. 2024 Feb 27;24(1):83. doi: 10.1186/s12871-024-02452-6.